State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 195 Dongfeng Xi Road, Guangzhou, 510182, Guangdong, China.
Department of Geriatrics, National Clinical Key Specialty, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Sci Rep. 2020 Jul 14;10(1):11587. doi: 10.1038/s41598-020-68327-1.
Traffic-related air pollution particulate matter 2.5 (TRAPM2.5), is involved in chronic obstructive pulmonary disease (COPD), which is characterized by airway inflammation. Specifically, these harmful particles or gases can increase chronic airway inflammation. Some recent studies have shown that lncRNAs are closely related to COPD and participate in the regulation of airway inflammation. However, the precise mechanisms remain unknown. In the present study, we investigated the effect of TRAPM2.5 on airway inflammation in human bronchial epithelial cells (HBECs) and the underlying mechanisms mediated by a lncRNA. After exposure to TRAPM2.5, the novel lncRNA RP11-86H7.1 was markedly upregulated in HBECs. Functional assays indicated that the lncRNA RP11-86H7.1 was required for the TRAPM2.5-induced expression of inflammatory factors in HBECs. A mechanistic study demonstrated that lncRNA RP11-86H7.1 might participate in TRAPM2.5-induced inflammatory responses by activating the NF-κB signaling pathway. Moreover, the lncRNA RP11-86H7.1 can promote the inflammatory response by acting as a competing endogenous RNA of miR-9-5p, reversing the inhibitory effect of its target gene NFKB1, and sustaining NF-κB activation. In summary, our study elucidates the pro-inflammatory roles of the lncRNA RP11-86H7.1-miR-9-5p-NFKB1 regulatory network in airway inflammation induced by TRAPM2.5 and indicates that the components of this network might serve as novel diagnostic biomarkers and potential therapeutic targets.
交通相关空气污染物 2.5(TRAPM2.5)与慢性阻塞性肺疾病(COPD)有关,其特征为气道炎症。具体而言,这些有害颗粒或气体可增加慢性气道炎症。一些最近的研究表明,lncRNAs 与 COPD 密切相关,并参与气道炎症的调节。然而,确切的机制尚不清楚。在本研究中,我们研究了 TRAPM2.5 对人支气管上皮细胞(HBECs)气道炎症的影响及其通过 lncRNA 介导的潜在机制。暴露于 TRAPM2.5 后,HBECs 中新型 lncRNA RP11-86H7.1 明显上调。功能测定表明,lncRNA RP11-86H7.1 是 TRAPM2.5 诱导 HBECs 中炎症因子表达所必需的。一项机制研究表明,lncRNA RP11-86H7.1 可能通过激活 NF-κB 信号通路参与 TRAPM2.5 诱导的炎症反应。此外,lncRNA RP11-86H7.1 可通过充当 miR-9-5p 的竞争性内源性 RNA 来促进炎症反应,逆转其靶基因 NFKB1 的抑制作用,并维持 NF-κB 激活。总之,我们的研究阐明了 lncRNA RP11-86H7.1-miR-9-5p-NFKB1 调节网络在 TRAPM2.5 诱导的气道炎症中的促炎作用,并表明该网络的组成部分可能作为新型诊断生物标志物和潜在治疗靶点。